藥物研發平台市場：按藥物類型、技術、治療領域、應用、最終用戶和地區分類

Drug Discovery Platforms Market, By Drug Type, By Technology, By Therapeutic Area, By Application, By End User, By Geography

出版日期: 2025年05月08日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球藥物研發平台市場規模估計為 2.113 億美元，預計到 2032 年將達到 5.129 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 13.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	2.113億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	13.50%	2032年價值預測	5.129億美元

近年來，全球藥物發現平台市場見證了顯著成長，這得益於對新型療法的需求不斷成長以及對更高效的藥物發現流程的需求。藥物發現平台利用高通量篩檢、基因組學、蛋白質組學和計算工具等先進技術，在識別和開發候選藥物方面發揮著至關重要的作用。這些平台使研究人員能夠簡化藥物發現流程、降低成本並縮短從初步篩檢到臨床試驗的時間。市場包括各種類型的平台，如生化檢測、基於細胞的檢測、In Silico模擬和基於片段的藥物發現。慢性病盛行率的不斷上升、個人化醫療的興起以及製藥公司和學術機構之間合作的日益增多，進一步推動了藥物發現平台的採用。

市場動態：

全球藥物發現平台市場受到多種因素驅動，包括慢性病盛行率上升、個人化醫療需求成長以及對更有效率的藥物發現流程的需求。癌症、心血管疾病和神經系統疾病盛行率上升導致對新型治療藥物的需求龐大，從而推動了藥物發現平台市場的成長。此外，向個人化醫療的轉變需要開發標靶治療，而標靶療法嚴重依賴藥物發現平台來識別特定的分子標靶並最佳化候選藥物。然而，藥物發現和上市的高成本以及藥物核准所需的嚴格監管要求制約了市場的成長。此外，熟練專業人員的短缺和整合各種技術的複雜性也對市場成長構成了挑戰。儘管存在這些市場限制因素，但市場提供了巨大的商機，包括在藥物發現中擴大採用人工智慧和機器學習、越來越關注罕見疾病以及製藥公司和技術提供商之間在開發創新藥物發現解決方案方面的潛在合作。

本研究的主要特點

本報告對全球藥物發現平台市場進行了詳細分析，並給出了預測期（2025-2032）的市場規模（百萬美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
它還強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球藥物發現平台市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球藥物發現平台市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球藥物發現平台市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 211.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	13.50%	2032 Value Projection:	USD 512.9 Mn

The global drug discovery platforms market has witnessed significant growth in recent years, driven by the increasing demand for novel therapeutics and the need for more efficient drug discovery processes. Drug discovery platforms play a crucial role in the identification and development of new drug candidates, utilizing advanced technologies such as high-throughput screening, genomics, proteomics, and computational tools. These platforms enable researchers to streamline the drug discovery process, reduce costs, and accelerate the timeline from initial screening to clinical trials. The market encompasses various types of platforms, including biochemical assays, cell-based assays, in silico modeling, and fragment-based drug discovery. The adoption of drug discovery platforms has been further fueled by the growing prevalence of chronic diseases, the emergence of personalized medicine, and the increasing collaboration between pharmaceutical companies and academic institutions.

Market Dynamics:

The global drug discovery platforms market is driven by several factors, including the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for more efficient drug discovery processes. The rising prevalence of cancer, cardiovascular diseases, and neurological disorders has created a significant demand for novel therapeutics, propelling the growth of the drug discovery platforms market. Additionally, the shift towards personalized medicine has necessitated the development of targeted therapies, which rely heavily on drug discovery platforms for identifying specific molecular targets and optimizing drug candidates. However, the market growth is restrained by the high cost associated with drug discovery and development, as well as the stringent regulatory requirements for drug approval. Furthermore, the lack of skilled professionals and the complexity of integrating various technologies pose challenges to market growth. Despite these restraints, the market presents significant opportunities, such as the increasing adoption of artificial intelligence and machine learning in drug discovery, the growing focus on rare diseases, and the potential for collaborations between pharmaceutical companies and technology providers to develop innovative drug discovery solutions.

Key Features of the Study:

This report provides in-depth analysis of the global drug discovery platforms market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global drug discovery platforms market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation, PerkinElmer, Merck KGaA, Roche Holding AG, QIAGEN, Bruker Corporation, Bio-Rad Laboratories, Illumina, Charles River Laboratories, Evotec, WuXi AppTec, Schrodinger, and Abcam
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global drug discovery platforms market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug discovery platforms market

Market Segmentation

Drug Type Insights (Revenue, USD Mn, 2020 - 2032)
- Small Molecule
- Large Molecule
Technology Insights (Revenue, USD Mn, 2020 - 2032)
- Genomics
- Proteomics
- Cell-Based Assays
- High-Throughput Screening (HTS)
- Bioinformatics
- Next-Generation Sequencing (NGS)
- Mass Spectrometry
- Imaging Technologies
- Microfluidics
- Artificial Intelligence (AI) & Machine Learning (ML)
Therapeutic Area Insights (Revenue, USD Mn, 2020 - 2032)
- Oncology
- Neurology
- Infectious And Immune System Diseases
- Digestive System Diseases
- Cardiovascular Diseases
- Diabetes
- Respiratory Disease
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Target Identification
- Target Validation
- Lead Discovery
- Lead Optimization
- Preclinical Testing
- Others (Clinical Trials, etc.)
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Biopharmaceutical Companies
- Academic and Research Institutes
- CROs/CDMOs
- Others
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Thermo Fisher Scientific
- Agilent Technologies
- Danaher Corporation
- PerkinElmer
- Merck KGaA
- Roche Holding AG
- QIAGEN
- Bruker Corporation
- Bio-Rad Laboratories
- Illumina
- Charles River Laboratories
- Evotec
- WuXi AppTec
- Schrodinger
- Abcam

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Drug Discovery Platforms Market, By Drug Type
- Global Drug Discovery Platforms Market, By Technology
- Global Drug Discovery Platforms Market, By Therapeutic Area
- Global Drug Discovery Platforms Market, By Application
- Global Drug Discovery Platforms Market, By End User
- Global Drug Discovery Platforms Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Drug Discovery Platforms Market, By Drug Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Large Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Drug Discovery Platforms Market, By Technology, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cell-Based Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
High-Throughput Screening (HTS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Bioinformatics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Imaging Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Microfluidics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Artificial Intelligence (AI) & Machine Learning (ML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Drug Discovery Platforms Market, By Therapeutic Area, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Infectious And Immune System Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Digestive System Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Drug Discovery Platforms Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Target Identification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Target Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Lead Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Lead Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Preclinical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Clinical Trials, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Drug Discovery Platforms Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
CROs/CDMOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Drug Discovery Platforms Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bruker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Schrodinger
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abcam
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies